7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
The DOI matches its Crossref record; 224 of the 225 references it cites were found in a registry or an index.
Abstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc22-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc22-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, for some individuals, glucose monitoring can provide insight into the impact of lifestyle and medication management on blood glucose and symptoms, particularly when combined with education and support (53).”
In the citing paper
“Technologies such as intermittently scanned or real-time continuous glucose monitoring (CGM) provide more information and may be useful for people with type 2 diabetes, particularly in those treated with insulin (53,56).”
In the citing paper
“Professional CGM, along with professional interpretation, patient education, and therapy adjustments, may help reduce hyper-and/or hypoglycemia, but rigorous data are lacking (105).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [105]
In the citing paper
“Consequently, both guidelines emphasize the concurrent use of 1) HbA1c as a metric upon which therapeutic targets are defined based on randomized controlled trial (RCT) data, 2) continuous glucose monitoring (CGM) to assess effectiveness and safety of treatment among patients at risk for hypoglycemia or to assess overall glycemia when HbA1c is inaccurate, and 3) self-monitoring of blood glucose as”
In the citing paper
“The ADA and KDIGO guidelines highlight the important role of CGM technology in improving diabetes management as a tool to identify and correct glycemic derangements, prevent hypoglycemia, direct medication management, and guide medical nutritional therapy and physical activity, as well as its rapid evolution in affordability and accuracy (2,37) (Supplementary Table 1).”
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069 · cited 1×
“A variety of metrics have been proposed (80) and are discussed in Section 6, “Glycemic Targets” (https://doi .”
BackgroundContinuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185 · cited 1×
“The primary outcome was met and showed benefit in adults of all ages (30,40,41,46,47, 49,51,52) including seniors (48).”
BackgroundInternational Standards Organization
(2010) · Encyclopedia of Nanoscience and Society · doi:10.4135/9781412972093.n191 · Cited by 1,071
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
Brown, S. A., Kovatchev, B. P., Raghinaru, D., Lum, J. W., Buckingham, B. A., Kudva, Y. C., Laffel, L. M., Levy, C. J., Pinsker, J. E., Wadwa, R. P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1907863 · Cited by 1,030
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Epidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Research works printed but not linked: 1
- Chandran, 2015, Adherence to insulin pen therapy is associated with reduction in healthcare costs among patients with type 2 diabetes mellitus, Am Health Drug Benefits, 8, 148
Cited by
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0034 · Cited by 2,104
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05787-2 · Cited by 1,048
de Boer, I. H., Khunti, K., Sadusky, T., Tuttle, K. R., Neumiller, J. J., Rhee, C. M., Rosas, S. E., Rossing, P., & Bakris, G. (2022) · Diabetes Care · doi:10.2337/dci22-0027 · Cited by 919
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
Battelino, T., Alexander, C. M., Amiel, S. A., Arreaza-Rubin, G., Beck, R. W., Bergenstal, R. M., Buckingham, B. A., Carroll, J., Ceriello, A., Chow, E., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00319-9 · Cited by 831
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
de Boer, I. H., Khunti, K., Sadusky, T., Tuttle, K. R., Neumiller, J. J., Rhee, C. M., Rosas, S. E., Rossing, P., & Bakris, G. (2022) · Kidney International · doi:10.1016/j.kint.2022.08.012 · Cited by 353
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Management of diabetes and hyperglycaemia in the hospital
Pasquel, F. J., Lansang, M. C., Dhatariya, K., & Umpierrez, G. E. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30381-8 · Cited by 329
Grunberger, G., Sherr, J., Allende, M., Blevins, T., Bode, B., Handelsman, Y., Hellman, R., Lajara, R., Roberts, V. L., Rodbard, D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.008 · Cited by 288
Advances in technology for management of type 1 diabetes
Beck, R. W., Bergenstal, R. M., Laffel, L. M., & Pickup, J. C. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31142-0 · Cited by 242
Pullano, S. A., Greco, M., Bianco, M. G., Foti, D., Brunetti, A., & Fiorillo, A. S. (2022) · Theranostics · doi:10.7150/thno.64035 · Cited by 210
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 205
Sendekie, A. K., Netere, A. K., Kasahun, A. E., & Belachew, E. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274971 · Cited by 151
Aronson, R., Brown, R. E., Chu, L., Bajaj, H. S., Khandwala, H., Abitbol, A., Malakieh, N., & Goldenberg, R. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14949 · Cited by 118
Continuous glucose monitoring for the routine care of type 2 diabetes mellitus
Ajjan, R. A., Battelino, T., Cos, X., Del Prato, S., Philips, J.-C., Meyer, L., Seufert, J., & Seidu, S. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00973-1 · Cited by 117
“Adopting CGM in this way in people with T2DM has been proposed 116 , and is also recommended in ADA guidance for technology use in diabetes mellitus 117 .”
Handelsman, Y., Butler, J., Bakris, G. L., DeFronzo, R. A., Fonarow, G. C., Green, J. B., Grunberger, G., Januzzi, J. L., Klein, S., Kushner, P. R., et al. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108389 · Cited by 119
Yoo, J. H., & Kim, J. H. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0271 · Cited by 119
Evolution of Diabetes Technology
Dovč, K., & Battelino, T. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.009 · Cited by 132
Expanding the Role of Continuous Glucose Monitoring in Modern Diabetes Care Beyond Type 1 Disease
Klupa, T., Czupryniak, L., Dzida, G. J., Fichna, P., Jarosz-Chobot, P. A., Gumprecht, J., Myśliwiec, M., Szadkowska, A., Bomba-Opon, D. A., Czajkowski, K., et al. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01431-3 · Cited by 94
Diabetes and cirrhosis: Current concepts on diagnosis and management
Castéra, L., & Cusi, K. J. (2023) · Hepatology · doi:10.1097/hep.0000000000000263 · Cited by 93
Freckmann, G., Eichenlaub, M., Waldenmaier, D., Pleus, S., Wehrstedt, S., Haug, C., Witthauer, L., Jendle, J., Hinzmann, R., Thomas, A., et al. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231190941 · Cited by 86
Lee, E. Y., Cha, S.-A., Yun, J.-S., Lim, S.-Y., Lee, J.-H., Ahn, Y.-B., Yoon, K.-H., Hyun, M. K., & Ko, S.-H. (2022) · Journal of Medical Internet Research · doi:10.2196/37430 · Cited by 83
Oser, T. K., Hall, T. L., Dickinson, L. M., Callen, E., Carroll, J. K., Nease, D. E., Michaels, L., & Oser, S. M. (2022) · The Annals of Family Medicine · doi:10.1370/afm.2876 · Cited by 72
Nimri, R., Nir, J., & Phillip, M. (2019) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001097 · Cited by 94
Recent Updates to Clinical Practice Guidelines for Diabetes Mellitus
Yu, J., Lee, S.-H., & Kim, M. K. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.105 · Cited by 65
Moon, S. J., Kim, K., Lee, W. J., Lee, M. Y., Vigersky, R., & Park, C. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14852 · Cited by 69
“For basal insulin-treated patients, a recent study showed that discontinuation of RT-CGM causes a deterioration of glycaemic control.(17,29) However, intermittent use of RT-CGM or FGM was shown to be effective in several RCTs performed in the population of solely or partially non-insulin users.”
ResultDavis, G. M., Peters, A. L., Bode, B. W., Carlson, A. L., Dumais, B., Vienneau, T. E., Huyett, L. M., & Ly, T. T. (2023) · Diabetes Care · doi:10.2337/dc22-1915 · Cited by 69
Glucose variability: a new risk factor for cardiovascular disease
Belli, M., Bellia, A., Sergi, D., Barone, L., Lauro, D., & Barillà, F. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02097-w · Cited by 76
Handelsman, Y., Anderson, J. E., Bakris, G. L., Ballantyne, C. M., Beckman, J. A., Bhatt, D. L., Bloomgarden, Z. T., Bozkurt, B., Budoff, M. J., Butler, J., et al. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108101 · Cited by 64
Digital Technology for Diabetes
Hughes, M. S., Addala, A., & Buckingham, B. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2215899 · Cited by 59
Szmuilowicz, E. D., Levy, C. J., Buschur, E. O., & Polsky, S. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0540 · Cited by 58
Grassi, B., Gómez, A. M., Calliari, L. E., Franco, D., Raggio, M., Riera, F., Castro, M., McVean, J., van den Heuvel, T., Arrieta, A., et al. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15023 · Cited by 55
Demeterco‐Berggren, C., Ebekozien, O. A., Noor, N., Rompicherla, S., Majidi, S., Jones, N. Y., McDonough, R., Odugbesan, O., Kim, A., Izquierdo, R. E., et al. (2022) · Clinical Diabetes · doi:10.2337/cd22-0073 · Cited by 62
Burnside, M. J., Williman, J. A., Davies, H. M., Jefferies, C., Paul, R. G., Wheeler, B. J., Wiltshire, E. J., Anderson, Y. C., & de Bock, M. I. (2022) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2022.100644 · Cited by 63
Diabetic ketoacidosis in pregnancy: clinical risk factors, presentation, and outcomes
Dhanasekaran, M., Mohan, S., Erickson, D., Shah, P., Szymanski, L., Adrian, V., & Egan, A. M. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac464 · Cited by 50
Talbo, M. K., Katz, A., Hill, L., Peters, T. M., Yale, J.-F., & Brazeau, A.-S. (2023) · eClinicalMedicine · doi:10.1016/j.eclinm.2023.102119 · Cited by 42
Barriers and Facilitators to Diabetes Device Adoption for People with Type 1 Diabetes
Tanenbaum, M. L., & COMMISSARIAT, P. V. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01469-w · Cited by 50
Bellido, V., Aguilera, E., Cardona‐Hernandez, R., Díaz-Soto, G., de Villar, N. G. P., César, M. J. P., & Ampudia‐Blasco, F. J. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221088601 · Cited by 46
Isitt, J. J., Roze, S., Sharland, H., Cogswell, G., Alshannaq, H. A., Norman, G. J., & Lynch, P. M. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01324-x · Cited by 43
Lu, J., Ying, Z., Wang, P., Fu, M., Han, C., & Zhang, M. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15328 · Cited by 39
PAULEY, M. E., Tommerdahl, K. L., Snell‐Bergeon, J. K., & Forlenza, G. P. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01799-x · Cited by 46
Addala, A., Ding, V. Y., Zaharieva, D. P., Bishop, F. K., Adams, A. S., King, A. C., Johari, R., Scheinker, D., Hood, K. K., Desai, M., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.8881 · Cited by 41
Cranston, I., Jamdade, V., Liao, B., & Newson, R. S. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02478-1 · Cited by 37
Identifying the deficiencies of currently available CGM to improve uptake and benefit
Barnard‐Kelly, K. D., Martínez‐Brocca, M. A., Glatzer, T., & Oliver, N. (2024) · Diabetic Medicine · doi:10.1111/dme.15338 · Cited by 37
Insight into continuous glucose monitoring: from medical basics to commercialized devices
Chmayssem, A., Nadolska, M., Tubbs, E., Sadowska, K., Vadgma, P., Shitanda, I., Tsujimura, S., Lattach, Y., Peacock, M., Tingry, S., et al. (2023) · Microchimica Acta · doi:10.1007/s00604-023-05743-w · Cited by 40
Prasad‐Reddy, L., Godina, A., Chetty, A. K., Close Concerns, S. F., & Isaacs, D. (2022) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2022.18.2.116 · Cited by 43
Vrany, E. A., Hill‐Briggs, F., Ephraim, P. L., Myers, A. K., Garnica, P., & Fitzpatrick, S. L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1083145 · Cited by 39
Continuous Glucose Monitoring to Optimize Management of Diabetes in Patients with Advanced CKD
Galindo, R. J., de Boer, I. H., Neumiller, J. J., & Tuttle, K. R. (2022) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04510422 · Cited by 36
Patent analysis of digital sensors for continuous glucose monitoring
Litvinova, O., Eitenberger, M., Bilir, A., Yeung, A. W. K., Parvanov, E. D., MohanaSundaram, A., Horbańczuk, J. O., Atanasov, A. G., & Willschke, H. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1205903 · Cited by 40
Cordero, T. L., Dai, Z., Arrieta, A., Niu, F., Vella, M., Shin, J., Rhinehart, A. S., McVean, J., Lee, S. W., Slover, R. H., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0123 · Cited by 30
Perioperative Care of Patients Using Wearable Diabetes Devices
Cruz, P., McKee, A. M., Chiang, H.-H., McGill, J. B., Hirsch, I. B., Ringenberg, K. J., & Wildes, T. S. (2024) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000007115 · Cited by 38
Professional Competencies for Diabetes Technology Use in the Care Setting
Patil, S. P., Albanese-O’Neill, A., Yehl, K., Seley, J. J., & Hughes, A. S. (2022) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106221120889 · Cited by 31
Scheinker, D., Gu, A., Grossman, J., Ward, A., Ayerdi, O., Miller, D., Leverenz, J. C., Hood, K. K., Lee, M. Y., Maahs, D. M., et al. (2022) · JMIR Diabetes · doi:10.2196/27284 · Cited by 34
Kang, H. S., Park, H. R., Kim, C., & Singh‐Carlson, S. (2022) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106221116899 · Cited by 31
Sun, C., Shenk, Z., Renda, S., Maruthur, N. M., Zheng, S., Perrin, N., Levin, S., & Han, H. (2023) · JMIR Diabetes · doi:10.2196/44283 · Cited by 32
Diabetes: the role of continuous glucose monitoring
Kluemper, J. R., Smith, A. C., & Wobeter, B. R. (2022) · Drugs in Context · doi:10.7573/dic.2021-9-13 · Cited by 33
Al‐Sofiani, M. E., Petrovski, G., Shaikh, A. A., Alguwaihes, A. M., Harbi, M. A., Mohannadi, D. A., Adjene, A., Al-Agha, A. E., Remeithi, S. S. A., Alamuddin, N., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15389 · Cited by 30
Chiang, S.-W., Liu, H.-W., Loh, E.-W., Tam, K.-W., Wang, J.-Y., Huang, W.-L., & Kuan, Y.-C. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.04.002 · Cited by 28
Ulrich, H., & Bowen, M. (2021) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2021.05.013 · Cited by 27
Gianini, A., Suklan, J., Skela‐Savič, B., Klemenčič, S., Battelino, T., Dovč, K., & Bratina, N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.967725 · Cited by 27
Pathak, S., Kearin, K., Kahkoska, A. R., Fuller, K. A., Staats, B. R., Albright, J., Stürmer, T., Buse, J. B., & Urick, B. Y. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0418 · Cited by 27
Been, R. A., Lameijer, A., Gans, R. O. B., van Beek, A. P., Kingsnorth, A. P., Choudhary, P., & van Dijk, P. R. (2024) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188241236289 · Cited by 31
MacLeod, J., & Vigersky, R. A. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221134546 · Cited by 29
Howe, C. J., Morone, J. F., Hawkes, C. P., & Lipman, T. H. (2023) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106221145323 · Cited by 28
Perioperative use and accuracy of continuous glucose monitoring: A systematic review
Carlier, L., de Ponthaud, C., Jacqueminet, S., Phan, F., Gaujoux, S., & Amouyal, C. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16583 · Cited by 30
Afraie, M., Bahrami, P., Kohnepoushi, P., Khateri, S., Majidi, L., Saed, L., Zamani, K., Mohammadi, H., Moradi, Y., & Moradpour, F. (2024) · Journal of Diabetes Research · doi:10.1155/2024/9960656 · Cited by 33
Mario, C. D., Genovese, S., Lanza, G. A., Mannucci, E., Marenzi, G., Sciatti, E., Pitocco, D., the Expert Panel Group, Avogaro, A., Bertuzzi, F., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01598-2 · Cited by 26
Interruption of Continuous Glucose Monitoring: Frequency and Adverse Consequences
Markov, A. M., Krutilova, P., Cedeno, A., McGill, J. B., & McKee, A. M. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231156572 · Cited by 25
Continuous Glucose Monitor: Reclaiming Type 2 Diabetes Self-efficacy and Mitigating Disparities
Ni, K., Tampe, C. A., Sol, K., Cervantes, L., & Pereira, R. I. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae125 · Cited by 22
From wearables to THINKables: artificial intelligence-enabled sensors for health monitoring
Mirmomeni, M., Fazio, T., von Cavallar, S., & Harrer, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819246-7.00012-7 · Cited by 30
Toschi, E. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.10.006 · Cited by 25
Crossen, S. S., Romero, C. C., Lewis, C., & Glaser, N. S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1063290 · Cited by 22
Tanenbaum, M. L., Zaharieva, D. P., Addala, A., Prahalad, P., Hooper, J., Leverenz, B., Cortes, A. L., Arrizon‐Ruiz, N., Pang, E., Bishop, F. K., et al. (2022) · Diabetic Medicine · doi:10.1111/dme.14923 · Cited by 22
Rizos, E. C., Kanellopoulou, A., Filis, P., Markozannes, G., Chaliasos, K., Ntzani, E., Tzamouranou, A., Tentolouris, N., & Tsilidis, K. K. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221123530 · Cited by 24
Zou, Y. L., Zhao, S., Li, G., & Zhang, C. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07864-z · Cited by 27
Cangelosi, G., Mancin, S., Palomares, S. M., Pantanetti, P., Quinzi, E., Debernardi, G., & Petrelli, F. (2024) · Diseases · doi:10.3390/diseases12080173 · Cited by 26
Thomsen, M. N., Skytte, M. J., Astrup, A. V., Deacon, C. F., Holst, J. J., Madsbad, S., Krarup, T., Haugaard, S. B., & Samkani, A. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.07.002 · Cited by 24
Assessment of Glucose Monitoring Adherence in Medicare Beneficiaries with Insulin-Treated Diabetes
Puckrein, G. A., Hirsch, I. B., Parkin, C. G., Taylor, B. T., Norman, G. J., Xu, L., & Marrero, D. G. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0377 · Cited by 23
Bradley, M. D., Arnold, M. E., Biskup, B., Campbell, T. M., Fuhrman, J., Guthrie, G. E., Kelly, J. H., Lacagnina, S., Loomis, J. F., McMacken, M. M., et al. (2022) · Clinical Diabetes · doi:10.2337/cd22-0009 · Cited by 23
Use of continuous glucose monitors in low‐ and middle‐income countries: A scoping review
Bernabé‐Ortiz, A., Carrillo-Larco, R. M., Safary, E., Vetter, B., & Lazo‐Porras, M. (2023) · Diabetic Medicine · doi:10.1111/dme.15089 · Cited by 21
Pérez, C. T., Chico, A. I., Azriel-Mira, S., Lardiés‐Sánchez, B., Peralta, F. G., de Diabetes-SEEN, T. Á., Jesús, A. F. A., Rodrigo, A. B., Bellido, V., Bellido-Guerrero, D., et al. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01417-1 · Cited by 25
Use of Diabetes Technologies and Retinopathy in Adults With Type 1 Diabetes
Liu, T. Y. A., Shpigel, J., Khan, F., Smith, K. E., Prichett, L. M., Channa, R., Kanbour, S., Jones, M., Abusamaan, M. S., Sidhaye, A. R., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.0728 · Cited by 25
Continuous glucose monitoring in primary care – are we there?
Martens, T. W. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000689 · Cited by 21
Intelligent Control with Artificial Neural Networks for Automated Insulin Delivery Systems
de Farias, J. L. C. B., & Bessa, W. M. (2022) · Bioengineering · doi:10.3390/bioengineering9110664 · Cited by 24
Dupenloup, P., Pei, R., Chang, A., Gao, M. Z., Prahalad, P., Johari, R., Schulman, K. A., Addala, A., Zaharieva, D. P., Maahs, D. M., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1021982 · Cited by 23
Zivojinovic, A. S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105605 · Cited by 22
Aleppo, G., DeSalvo, D. J., Lauand, F., Huyett, L. M., Chang, A., Vienneau, T., & Ly, T. T. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01366-9 · Cited by 19
Modzelewski, K. L., Murati, J., Charoenngam, N., Rehm, C., & Steenkamp, D. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0557 · Cited by 19
Orozco‐Beltrán, D., Morales, C., Artola‐Menéndez, S., Brotons, C., Carrascosa, S., González, C., Baró, O., Verdugo, A. A., de Campos, K. F., Villarejo, M., et al. (2022) · JMIR Diabetes · doi:10.2196/40377 · Cited by 21
Addala, A., Filipp, S. L., Figg, L. E., ANEZ-ZABALA, C., Lal, R., Gurka, M. J., Haller, M. J., Maahs, D. M., & Walker, A. F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1066521 · Cited by 20
Williams, D. M., Parsons, S. N., Dunseath, G. J., Stephens, J. W., Luzio, S. D., & Owens, D. R. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.01.006 · Cited by 20
Chien, A., THANASEKARAN, S., Gaetano, A., IM, G. H., Wherry, K., MacLeod, J., & Vigersky, R. A. (2023) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2023.22283 · Cited by 20
BISKUPIAK, J. E., Ramos, M., Levy, C. J., Forlenza, G. P., Hopley, C. D. J., Boyd, J., Swift, D., Lamotte, M., & Brixner, D. I. (2023) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2023.22331 · Cited by 20
Mannoubi, C., Kairy, D., Menezes, K. V. R. S., Desroches, S., Layani, G., & Vachon, B. (2024) · JMIR Medical Informatics · doi:10.2196/46699 · Cited by 22
William, J., McCluskey, J. T., & Gleeson, N. (2022) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.324 · Cited by 21
Galindo, R. J., Aleppo, G., Parkin, C. G., Baidal, D. A., Carlson, A. L., Cengiz, E., Forlenza, G. P., Kruger, D. F., Levy, C. J., McGill, J. B., et al. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221144052 · Cited by 19
Zheng, Y., Campbell Rice, B., Melkus, G. D., Sun, M., Zweig, S., Jia, W., Parekh, N., He, H., Zhang, Y., & Wylie-Rosett, J. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231174038 · Cited by 17
Continuous Glucose Monitoring for Prediabetes: Roles, Evidence, and Gaps
Zahalka, S. J., Aktürk, H. K., Galindo, R. J., Shah, V. N., & Wang, C. C. L. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.05.742 · Cited by 193
Use of continuous glucose monitoring in insulin-treated older adults with type 2 diabetes
Leite, S. A. O., da Silva, M. P., Lavalle, A. C. R., Bertogy, M. C. V., Bastos, M., Kuklik, S. C. V., & Umpierrez, G. E. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01225-4 · Cited by 18
The Role of a Smart Health Ecosystem in Transforming the Management of Chronic Health Conditions
Nourse, R. A., Dingler, T., Kelly, J. T., Kwaśnicka, D., & Maddison, R. (2023) · Journal of Medical Internet Research · doi:10.2196/44265 · Cited by 20
Metadata
- Authors
- American Diabetes Association Professional Practice Committee
- Corresponding author
- American Diabetes Association Professional Practice Committee
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2021-12-16
- Volume
- 45
- Issue
- Supplement_1
- Pages
- S97-S112
- ISSN
- 0149-5992 (ISSN-L)
- OpenAlex
- W4200316649
- Semantic Scholar
- 485b3c0c22c51827fd245d87ab7936a39cae732b
- Cited by
- 358
- References
- 225
- Citations by year
- 2026: 21 · 2025: 34 · 2024: 49 · 2023: 106 · 2022: 98 · 2021: 27
- FWCI
- 10.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- diabetes technology, clinical guidelines, treatment goals, quality of care, diabetes management
- MeSH terms
- Diabetes Mellitus, Endocrinology, Humans, Reference Standards, Societies, Medical, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.